HEADER TRANSFERASE/TRANSFERASE INHIBITOR 19-AUG-20 7JU6 TITLE STRUCTURE OF RET PROTEIN TYROSINE KINASE IN COMPLEX WITH SELPERCATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CADHERIN FAMILY MEMBER 12,PROTO-ONCOGENE C-RET; COMPND 5 EC: 2.7.10.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RET, CDHF12, CDHR16, PTC, RET51; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA AFF. FRUGIPERDA 2 RZ-2014; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1491790; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBACPAK6 KEYWDS TRANSFERASE, ONCOGENE, RET, TYRISINE KINASE, ATP BINDING, THYROID KEYWDS 2 CANCER, NON SMALL CELL LUNG CANCER, LOXO-292, SELPERCATINIB, KEYWDS 3 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.S.TERZYAN,T.SHEN,J.WU,B.H.M.MOOERS REVDAT 4 18-OCT-23 7JU6 1 REMARK REVDAT 3 27-JAN-21 7JU6 1 JRNL REVDAT 2 25-NOV-20 7JU6 1 JRNL REVDAT 1 11-NOV-20 7JU6 0 JRNL AUTH V.SUBBIAH,T.SHEN,S.S.TERZYAN,X.LIU,X.HU,K.P.PATEL,M.HU, JRNL AUTH 2 M.CABANILLAS,A.BEHRANG,F.MERIC-BERNSTAM,P.T.T.VO, JRNL AUTH 3 B.H.M.MOOERS,J.WU JRNL TITL STRUCTURAL BASIS OF ACQUIRED RESISTANCE TO SELPERCATINIB AND JRNL TITL 2 PRALSETINIB MEDIATED BY NON-GATEKEEPER RET MUTATIONS. JRNL REF ANN ONCOL V. 32 261 2021 JRNL REFN ISSN 1569-8041 JRNL PMID 33161056 JRNL DOI 10.1016/J.ANNONC.2020.10.599 REMARK 2 REMARK 2 RESOLUTION. 2.06 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.06 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 78.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 3 NUMBER OF REFLECTIONS : 35183 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1848 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.06 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.12 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2308 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.38 REMARK 3 BIN R VALUE (WORKING SET) : 0.3140 REMARK 3 BIN FREE R VALUE SET COUNT : 122 REMARK 3 BIN FREE R VALUE : 0.3390 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4622 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 93 REMARK 3 SOLVENT ATOMS : 146 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.09 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.24000 REMARK 3 B22 (A**2) : -0.03000 REMARK 3 B33 (A**2) : -1.14000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.01000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.239 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.199 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.170 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.724 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4956 ; 0.008 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6709 ; 1.285 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 612 ; 5.033 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 213 ;37.748 ;23.427 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 904 ;15.910 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 37 ;19.209 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 718 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3711 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7JU6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-AUG-20. REMARK 100 THE DEPOSITION ID IS D_1000251354. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUL-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : RH COATED COLLIMATOR REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37447 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.84400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC 5.8.0073 REMARK 200 STARTING MODEL: 6NEC REMARK 200 REMARK 200 REMARK: TRANSPARENT SMALL CRYSTALS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 21-30% PEG3350 0.1M NA CITRATE PH5.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.98750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 700 REMARK 465 PRO A 701 REMARK 465 LEU A 702 REMARK 465 SER A 703 REMARK 465 LEU A 704 REMARK 465 SER A 705 REMARK 465 VAL A 706 REMARK 465 ASP A 707 REMARK 465 ALA A 708 REMARK 465 PHE A 709 REMARK 465 LYS A 710 REMARK 465 ILE A 711 REMARK 465 LEU A 712 REMARK 465 SER A 829 REMARK 465 GLY A 830 REMARK 465 GLY A 831 REMARK 465 SER A 832 REMARK 465 ARG A 833 REMARK 465 ASN A 834 REMARK 465 SER A 835 REMARK 465 SER A 836 REMARK 465 SER A 837 REMARK 465 LEU A 838 REMARK 465 ASP A 839 REMARK 465 HIS A 840 REMARK 465 ARG A 1013 REMARK 465 PRO B 824 REMARK 465 GLY B 825 REMARK 465 TYR B 826 REMARK 465 LEU B 827 REMARK 465 GLY B 828 REMARK 465 SER B 829 REMARK 465 GLY B 830 REMARK 465 GLY B 831 REMARK 465 SER B 832 REMARK 465 ARG B 833 REMARK 465 ASN B 834 REMARK 465 SER B 835 REMARK 465 SER B 836 REMARK 465 TYR B 900 REMARK 465 GLU B 901 REMARK 465 GLU B 902 REMARK 465 ASP B 903 REMARK 465 SER B 904 REMARK 465 TYR B 905 REMARK 465 VAL B 906 REMARK 465 LYS B 907 REMARK 465 ARG B 908 REMARK 465 ARG B 1013 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 735 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PRO A 841 CG CD REMARK 470 GLU A 971 CD OE1 OE2 REMARK 470 GLU A 991 CD OE1 OE2 REMARK 470 LYS A1003 CD CE NZ REMARK 470 ARG B 770 NE CZ NH1 NH2 REMARK 470 GLU B 843 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 841 N - CA - CB ANGL. DEV. = 7.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 735 16.62 59.00 REMARK 500 GLN A 796 -69.87 -108.03 REMARK 500 ASP A 797 40.55 -80.08 REMARK 500 ARG A 873 -28.92 78.36 REMARK 500 ASP A 892 74.93 61.42 REMARK 500 GLU A 902 -13.43 89.82 REMARK 500 ASN A 975 30.55 -96.52 REMARK 500 LYS A1011 40.18 -87.44 REMARK 500 LYS A1011 38.24 -87.44 REMARK 500 ARG B 873 -30.91 78.98 REMARK 500 ASP B 892 75.80 59.88 REMARK 500 REMARK 500 REMARK: NULL DBREF 7JU6 A 705 1013 UNP P07949 RET_HUMAN 705 1013 DBREF 7JU6 B 705 1013 UNP P07949 RET_HUMAN 705 1013 SEQADV 7JU6 GLY A 700 UNP P07949 EXPRESSION TAG SEQADV 7JU6 PRO A 701 UNP P07949 EXPRESSION TAG SEQADV 7JU6 LEU A 702 UNP P07949 EXPRESSION TAG SEQADV 7JU6 SER A 703 UNP P07949 EXPRESSION TAG SEQADV 7JU6 LEU A 704 UNP P07949 EXPRESSION TAG SEQADV 7JU6 GLY B 700 UNP P07949 EXPRESSION TAG SEQADV 7JU6 PRO B 701 UNP P07949 EXPRESSION TAG SEQADV 7JU6 LEU B 702 UNP P07949 EXPRESSION TAG SEQADV 7JU6 SER B 703 UNP P07949 EXPRESSION TAG SEQADV 7JU6 LEU B 704 UNP P07949 EXPRESSION TAG SEQRES 1 A 314 GLY PRO LEU SER LEU SER VAL ASP ALA PHE LYS ILE LEU SEQRES 2 A 314 GLU ASP PRO LYS TRP GLU PHE PRO ARG LYS ASN LEU VAL SEQRES 3 A 314 LEU GLY LYS THR LEU GLY GLU GLY GLU PHE GLY LYS VAL SEQRES 4 A 314 VAL LYS ALA THR ALA PHE HIS LEU LYS GLY ARG ALA GLY SEQRES 5 A 314 TYR THR THR VAL ALA VAL LYS MET LEU LYS GLU ASN ALA SEQRES 6 A 314 SER PRO SER GLU LEU ARG ASP LEU LEU SER GLU PHE ASN SEQRES 7 A 314 VAL LEU LYS GLN VAL ASN HIS PRO HIS VAL ILE LYS LEU SEQRES 8 A 314 TYR GLY ALA CYS SER GLN ASP GLY PRO LEU LEU LEU ILE SEQRES 9 A 314 VAL GLU TYR ALA LYS TYR GLY SER LEU ARG GLY PHE LEU SEQRES 10 A 314 ARG GLU SER ARG LYS VAL GLY PRO GLY TYR LEU GLY SER SEQRES 11 A 314 GLY GLY SER ARG ASN SER SER SER LEU ASP HIS PRO ASP SEQRES 12 A 314 GLU ARG ALA LEU THR MET GLY ASP LEU ILE SER PHE ALA SEQRES 13 A 314 TRP GLN ILE SER GLN GLY MET GLN TYR LEU ALA GLU MET SEQRES 14 A 314 LYS LEU VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU SEQRES 15 A 314 VAL ALA GLU GLY ARG LYS MET LYS ILE SER ASP PHE GLY SEQRES 16 A 314 LEU SER ARG ASP VAL TYR GLU GLU ASP SER TYR VAL LYS SEQRES 17 A 314 ARG SER GLN GLY ARG ILE PRO VAL LYS TRP MET ALA ILE SEQRES 18 A 314 GLU SER LEU PHE ASP HIS ILE TYR THR THR GLN SER ASP SEQRES 19 A 314 VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE VAL THR SEQRES 20 A 314 LEU GLY GLY ASN PRO TYR PRO GLY ILE PRO PRO GLU ARG SEQRES 21 A 314 LEU PHE ASN LEU LEU LYS THR GLY HIS ARG MET GLU ARG SEQRES 22 A 314 PRO ASP ASN CYS SER GLU GLU MET TYR ARG LEU MET LEU SEQRES 23 A 314 GLN CYS TRP LYS GLN GLU PRO ASP LYS ARG PRO VAL PHE SEQRES 24 A 314 ALA ASP ILE SER LYS ASP LEU GLU LYS MET MET VAL LYS SEQRES 25 A 314 ARG ARG SEQRES 1 B 314 GLY PRO LEU SER LEU SER VAL ASP ALA PHE LYS ILE LEU SEQRES 2 B 314 GLU ASP PRO LYS TRP GLU PHE PRO ARG LYS ASN LEU VAL SEQRES 3 B 314 LEU GLY LYS THR LEU GLY GLU GLY GLU PHE GLY LYS VAL SEQRES 4 B 314 VAL LYS ALA THR ALA PHE HIS LEU LYS GLY ARG ALA GLY SEQRES 5 B 314 TYR THR THR VAL ALA VAL LYS MET LEU LYS GLU ASN ALA SEQRES 6 B 314 SER PRO SER GLU LEU ARG ASP LEU LEU SER GLU PHE ASN SEQRES 7 B 314 VAL LEU LYS GLN VAL ASN HIS PRO HIS VAL ILE LYS LEU SEQRES 8 B 314 TYR GLY ALA CYS SER GLN ASP GLY PRO LEU LEU LEU ILE SEQRES 9 B 314 VAL GLU TYR ALA LYS TYR GLY SER LEU ARG GLY PHE LEU SEQRES 10 B 314 ARG GLU SER ARG LYS VAL GLY PRO GLY TYR LEU GLY SER SEQRES 11 B 314 GLY GLY SER ARG ASN SER SER SER LEU ASP HIS PRO ASP SEQRES 12 B 314 GLU ARG ALA LEU THR MET GLY ASP LEU ILE SER PHE ALA SEQRES 13 B 314 TRP GLN ILE SER GLN GLY MET GLN TYR LEU ALA GLU MET SEQRES 14 B 314 LYS LEU VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU SEQRES 15 B 314 VAL ALA GLU GLY ARG LYS MET LYS ILE SER ASP PHE GLY SEQRES 16 B 314 LEU SER ARG ASP VAL TYR GLU GLU ASP SER TYR VAL LYS SEQRES 17 B 314 ARG SER GLN GLY ARG ILE PRO VAL LYS TRP MET ALA ILE SEQRES 18 B 314 GLU SER LEU PHE ASP HIS ILE TYR THR THR GLN SER ASP SEQRES 19 B 314 VAL TRP SER PHE GLY VAL LEU LEU TRP GLU ILE VAL THR SEQRES 20 B 314 LEU GLY GLY ASN PRO TYR PRO GLY ILE PRO PRO GLU ARG SEQRES 21 B 314 LEU PHE ASN LEU LEU LYS THR GLY HIS ARG MET GLU ARG SEQRES 22 B 314 PRO ASP ASN CYS SER GLU GLU MET TYR ARG LEU MET LEU SEQRES 23 B 314 GLN CYS TRP LYS GLN GLU PRO ASP LYS ARG PRO VAL PHE SEQRES 24 B 314 ALA ASP ILE SER LYS ASP LEU GLU LYS MET MET VAL LYS SEQRES 25 B 314 ARG ARG HET Q6G A1101 39 HET FMT A1102 3 HET FMT A1103 3 HET FMT A1104 3 HET FMT A1105 3 HET Q6G B1101 39 HET FMT B1102 3 HETNAM Q6G SELPERCATINIB HETNAM FMT FORMIC ACID HETSYN Q6G 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-{(1R,5S)-6-[(6- HETSYN 2 Q6G METHOXYPYRIDIN-3-YL)METHYL]-3,6- HETSYN 3 Q6G DIAZABICYCLO[3.1.1]HEPTAN-3-YL}PYRIDIN-3-YL) HETSYN 4 Q6G PYRAZOLO[1,5-A]PYRIDINE-3-CARBONITRILE FORMUL 3 Q6G 2(C29 H31 N7 O3) FORMUL 4 FMT 5(C H2 O2) FORMUL 10 HOH *146(H2 O) HELIX 1 AA1 PRO A 720 LYS A 722 5 3 HELIX 2 AA2 LEU A 746 ARG A 749 5 4 HELIX 3 AA3 SER A 765 LYS A 780 1 16 HELIX 4 AA4 LEU A 812 SER A 819 1 8 HELIX 5 AA5 MET A 848 MET A 868 1 21 HELIX 6 AA6 ALA A 876 ARG A 878 5 3 HELIX 7 AA7 PRO A 914 MET A 918 5 5 HELIX 8 AA8 ALA A 919 HIS A 926 1 8 HELIX 9 AA9 THR A 929 THR A 946 1 18 HELIX 10 AB1 PRO A 956 GLU A 958 5 3 HELIX 11 AB2 ARG A 959 THR A 966 1 8 HELIX 12 AB3 SER A 977 TRP A 988 1 12 HELIX 13 AB4 GLU A 991 ARG A 995 5 5 HELIX 14 AB5 VAL A 997 LYS A 1011 1 15 HELIX 15 AB6 PRO B 701 ILE B 711 1 11 HELIX 16 AB7 PRO B 720 LYS B 722 5 3 HELIX 17 AB8 LEU B 746 ARG B 749 5 4 HELIX 18 AB9 SER B 765 GLN B 781 1 17 HELIX 19 AC1 LEU B 812 GLU B 818 1 7 HELIX 20 AC2 THR B 847 MET B 868 1 22 HELIX 21 AC3 ALA B 876 ARG B 878 5 3 HELIX 22 AC4 PRO B 914 MET B 918 5 5 HELIX 23 AC5 ALA B 919 HIS B 926 1 8 HELIX 24 AC6 THR B 929 THR B 946 1 18 HELIX 25 AC7 PRO B 956 GLU B 958 5 3 HELIX 26 AC8 ARG B 959 THR B 966 1 8 HELIX 27 AC9 SER B 977 TRP B 988 1 12 HELIX 28 AD1 GLU B 991 ARG B 995 5 5 HELIX 29 AD2 VAL B 997 LYS B 1011 1 15 SHEET 1 AA1 5 LEU A 724 GLU A 732 0 SHEET 2 AA1 5 GLY A 736 PHE A 744 -1 O VAL A 738 N LEU A 730 SHEET 3 AA1 5 TYR A 752 LEU A 760 -1 O VAL A 757 N VAL A 739 SHEET 4 AA1 5 LEU A 801 GLU A 805 -1 O LEU A 802 N LYS A 758 SHEET 5 AA1 5 LEU A 790 CYS A 794 -1 N GLY A 792 O ILE A 803 SHEET 1 AA2 3 GLY A 810 SER A 811 0 SHEET 2 AA2 3 ILE A 880 ALA A 883 -1 O VAL A 882 N GLY A 810 SHEET 3 AA2 3 LYS A 887 ILE A 890 -1 O LYS A 889 N LEU A 881 SHEET 1 AA3 2 GLY A 825 GLY A 828 0 SHEET 2 AA3 2 ALA A 845 THR A 847 1 O LEU A 846 N LEU A 827 SHEET 1 AA4 2 LEU A 870 VAL A 871 0 SHEET 2 AA4 2 ARG A 897 ASP A 898 -1 O ARG A 897 N VAL A 871 SHEET 1 AA5 2 TYR A 905 VAL A 906 0 SHEET 2 AA5 2 ILE A 927 TYR A 928 -1 O TYR A 928 N TYR A 905 SHEET 1 AA6 5 LEU B 724 GLU B 732 0 SHEET 2 AA6 5 GLY B 736 PHE B 744 -1 O LYS B 740 N GLY B 727 SHEET 3 AA6 5 TYR B 752 LEU B 760 -1 O VAL B 757 N VAL B 739 SHEET 4 AA6 5 LEU B 801 GLU B 805 -1 O VAL B 804 N ALA B 756 SHEET 5 AA6 5 LEU B 790 CYS B 794 -1 N GLY B 792 O ILE B 803 SHEET 1 AA7 3 GLY B 810 SER B 811 0 SHEET 2 AA7 3 ILE B 880 ALA B 883 -1 O VAL B 882 N GLY B 810 SHEET 3 AA7 3 LYS B 887 ILE B 890 -1 O LYS B 889 N LEU B 881 SHEET 1 AA8 2 SER B 819 LYS B 821 0 SHEET 2 AA8 2 ARG B 844 LEU B 846 1 O LEU B 846 N ARG B 820 SHEET 1 AA9 2 LEU B 870 VAL B 871 0 SHEET 2 AA9 2 ARG B 897 ASP B 898 -1 O ARG B 897 N VAL B 871 LINK O1 FMT A1102 C FMT A1103 1555 1555 1.51 LINK C FMT A1102 C FMT A1104 1555 1555 1.37 LINK C FMT A1103 O2 FMT A1104 1555 1555 1.45 LINK O2 FMT A1103 C FMT A1104 1555 1555 1.34 CISPEP 1 GLY A 823 PRO A 824 0 -0.68 CRYST1 50.621 79.975 79.839 90.00 100.09 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019755 0.000000 0.003514 0.00000 SCALE2 0.000000 0.012504 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012722 0.00000